Events

Royalty Pharma published press releases by date and/or category

Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference

NEW YORK , NY, November 28, 2022 - Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 5^th Annual HealthCONx Virtual Conference on November 30, 2022 at 10:30 a.m. ET .

Royalty Pharma to Present at Upcoming Investor Conferences

Events

NEW YORK, NY, September 6, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September: Citi’s 17th Annual BioPharma Conference on Thursday, September 8 at 11:20 a.m.

Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

Events

NEW YORK, NY, June 8, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman Sachs 43 rd Annual Global Healthcare Conference on June 14, 2022 at 2:20 p.m. ET.

Royalty Pharma to Present at the UBS Global Healthcare Conference 2022

Events

NEW YORK, NY, May 23, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the UBS Global Healthcare Conference 2022 on May 24, 2022 at 1:15 p.m. ET. The webcast will be accessible from Royalty

Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders

Earnings, Events

NEW YORK, NY, May 17, 2022 – Royalty Pharma plc (Nasdaq: RPRX) will host its inaugural Investor Day in New York City today. Royalty Pharma’s management team will provide an update on the company’s capital deployment

Royalty Pharma to Present at Cowen’s 42nd Annual Health Care Conference

Events

NEW YORK, NY, March 3, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at Cowen’s 42nd Annual Health Care Conference on March 8, 2022 at 11:10 a.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at

Royalty Pharma Announces Inaugural Investor Day

Earnings, Events

NEW YORK, NY, February 16, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an inaugural Investor Day in New York City on Tuesday, May 17, 2022, starting at 8:30 a.m. ET. Royalty Pharma senior executives will present on the outlook for royalty funding in life sciences

Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J.P. Morgan Healthcare Conference

Events

NEW YORK, NY, January 10, 2022 - Royalty Pharma plc (Nasdaq: RPRX) today provided an update on its business performance, including recent key accomplishments and the full-year 2021 outlook for Net cash provided by operating activities (a GAAP financial measure) and Adjusted Cash Receipts

Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 10

Events

NEW YORK, NY, January 5, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 8:15 a.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at

Royalty Pharma to Present at Evercore ISI 4th Annual Healthconx Virtual Conference

Events

NEW YORK, NY, November 29, 2021 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 4 th Annual HealthCONx Virtual Conference on December 2, 2021 at 9:40 a.m. ET. The webcast will be accessible from Royalty Pharma’s

Events

Stay up to date